info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
 
Home » Healthcare » DNA Sequencing Market Size | Growth Trends, Report 2030

DNA Sequencing Market By End-Use (Academic Research, Clinical Research, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other Users), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Product (Consumables, Instruments, Services), By Geography, Size, Share and Global Report, Forecast 2021-2030

Published On: Apr-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2015 - 2019   |   Formats: PDF   |   Report ID: 46599212

Industry Report and Statistics (Facts & Figures) - Number of Test Conducted, Demand & Sales Analysis by Product & End-User

The global DNA sequencing market will witness a robust CAGR of 17.12%, valued at $10.5 billion in 2021, expected to appreciate and reach $44 billion by 2030, confirms Strategic Market Research. In 2019, North America had the highest DNA sequencing market size, with 44.3% of its total revenue share. DNA sequencing is a laboratory method to determine the sequences of bases {adenine (A), cytosine (C), guanine (G) and thymine (T)} in a DNA molecule. A sample containing the DNA to be sequenced is prepared. The target sequence is then amplified using polymerase chain reaction (PCR). The amplicons obtained are then purified thoroughly, followed by preparations for the sequencing of the DNA. The DNA is then sequenced to obtain the required data, which is then analyzed thoroughly. It has been declared by the National Human Genome Research Institute (NHGRI) that all human beings are 99.9% identical in their genetic makeup. The remaining 0.1% is studied using DNA sequencing to determine the causes of the diseases. This technique has extensive applications in molecular biology, evolutionary biology, metagenomics, virology, medicine, and forensic investigations.

DNA sequencing Market Based on Market Share

 

Market Drivers - Technological Advancements in DNA sequencing, Increasing Application in Clinical Diagnosis and Drug Discovery

  • Technological improvements in DNA sequencing have helped immensely to drive the market growth. According to the NHGRI, since the completion of the Human Genome Project, technological advancements and improvements have gained speed and lowered costs to a point where some labs can sequence over 100 trillion bases per year. DNA sequencing equipment like the Biomek 4000, Hudson Robotics SOLO, Formulatrix Mantis, Hamilton Microlab NIMBUS, Hamilton Genomic STARlet, Eppendorf epMotion 5075t, Beckman Coulter Biomek i5, Tecan NGS, PerkinElmer Sciclone G3 NGS and NGSx Workstation, Hamilton NGS STAR, Beckman Coulter Biomek i7, and the Agilent Bravo NGS have ameliorated the process involved in DNA sequencing.

 

  • DNA sequencing technology held more significant potential in clinical research. According to the NIH, about 7000 rare diseases affect 25 to 30 million Americans. Rare diseases are mostly caused by genetic disorders. Thus, genomic sequencing-based diagnosis can be used in rare-disease management, positively impacting the market growth.

     

 

Market Restraints - High Costs, Lack of Professional Expertise and  Data Privacy

  • The machines used in different stages of DNA sequencing are found to be expensive. The National Human Genome Research Institute estimated that the total cost of the procedure amounts to around USD 300 million. This could hinder DNA sequencing, causing a roadblock in its market growth.

 

  • Professional expertise in DNA sequencing is not available everywhere. Thus, niche methods and products in DNA sequencing take a longer time to be discovered, thus impeding the market growth.

 

  • Genetic data privacy is a significant concern for patients, hindering the market growth. According to a study by the NCBI, only 10% of biopharmaceutical companies completely anonymized their data. The non-anonymization of data by such companies could lead to data theft and exploitation by different companies, which could impede the market growth.

 

Market Opportunities - Adoption of Newer Procedures

  • The increased usage of newer procedures in DNA sequencing can eventually boost the market growth. Methods like high-throughput sequencing, ion-torrent sequencing, pyrosequencing, single-molecule real-time sequencing, sequencing by synthesis, sequencing by ligation, combinatorial probe anchor synthesis, GenapSys sequencing, Sanger sequencing and Nanopore sequencing that employ electrical tunnelling, hybridisation, mass spectrometry, in vitro virus mRNA display, microscopy and microfluidics that can be used in DNA sequencing, DNA synthesis, RNA sequencing, gene sequencing, and sample preparation for DNA and RNA polymerase are expected to provide ample growth opportunities for the market in future.

 

  • Further, Newer cDNA sequencing methods are also being discovered. It is also because cDNA sequencing methods are regarded as one of the major opportunity providers for market growth in the future. A cDNA is a DNA strand generated in vitro from cellular mRNA.

 

Market Analysis Of Different Segments Covered in the Report

Based on Product

  • Consumables

  • Instruments

  • Services

 

Based on Technology

  • Sanger Sequencing

  • Next-Generation Sequencing (NGS)

    • Whole Genome Sequencing (WGS)

    • Whole Exome Sequencing (WES)

    • Targeted Sequencing and Resequencing

  • Third Generation DNA Sequencing

    • Single-Molecule Real-Time Sequencing (SMRT)

    • Nanopore Sequencing

 

Based on Workflow

  • Pre-sequencing

  • Sequencing

  • Data Analysis

 

Based on Application

  • Oncology

  • Reproductive health

  • Clinical Investigation

  • Agri genomics and Forensics

  • HLA Typing/Immune System Monitoring

  • Metagenomics, Epidemiology and Drug Development

  • Consumer Genomics

  • Others

 

Based on End-Use

  • Academic Research

  • Clinical Research

  • Hospitals and Clinics

  • Pharmaceutical and Biotechnology Companies

  • Other Users

DNA sequencing Market Based on Application

Regional Coverage Analysis

North America

  • United States of America

  • Canada

  • Mexico

  • Rest of North America

 

Europe

  • Germany

  • United Kingdom

  • France

  • Italy

  • Spain

  • Rest of Europe

 

Asia-Pacific

  • China

  • Japan

  • India

  • Rest of APAC

 

LAMEA

  • Brazil

  • Argentina

  • UAE

  • Rest of LAMEA

 

Segments Analysis & Insights

Based on product, Consumables held the largest DNA sequencing market share of 43% in 2019. The wide availability of reagents and kits to cater to library construction, such as DNA fragmentation, enrichment, adapter ligation, amplification, and quality control, contributed to the maximum share in this segment.

 

Based on technology, the Next-Generation Sequencing (NGS) segment held the largest market share of 58.6% in 2019. Next-Generation Sequencing is the method of high-throughput DNA sequencing to determine the complete genome sequence of an organism. The advances in technology and the reducing cost of sequencing have made genome sequencing faster, more affordable, and more accurate. According to a study published in the NCBI, NGS usually took less than a day to complete. In contrast, Sanger sequencing took over a decade. According to National Human Genome Research Institute, due to continuous innovations, the cost of NGS per genome is USD 562, and the cost of NGS per megabase is USD 0.006 in August 2021. According to the American Journal of Clinical Pathology, 98.7% of DNA sequencing cases using NGS were successful. The whole-genome sequencing market size is expected to grow significantly from 2020 to 2030. Whole-genome sequencing was instrumental in determining the virus behind COVID-19.

 

Based on workflow, the Sequencing segment held the maximum revenue share of 52.9% in 2019. Sequencing enables the sequence profiling of the genome and DNA-protein interactions.

 

Based on application, the Oncology segment comprehensively dominated the market for DNA sequencing with a share of 24.4% in 2019. This technology has the maximum potential for developing cancer diagnostics and therapeutics. According to the National Centre for Health Statistics, around 2 million new cancer cases and 600,000 cancer-related deaths are expected by 2022. The increasing number of cancer cases proliferates the demand for new cancer diagnostics and therapeutics, which drives the segment’s growth.

The metagenomics, epidemiology and DNA sequencing in the drug discovery market segment is expected to grow at a CAGR of around 17.5 per cent from 2020 to 2030. According to the American Society for Clinical Pharmaceuticals and Therapeutics, the success rate of a drug, from inception to market approval, is only 10-20%. DNA sequencing can be used to improve the success rate, which would boost this segment’s market growth further.

 

Based on end-use, the academic research segment dominated the market with a revenue share of 55.4% in 2019 due to the increased acceptance and usage of Sanger technology and NGS in academic and institutional research projects.

 

Based on Region, North America has dominated significantly with a market revenue share of 44.3% in 2019. High investment in R&D, continuous technological developments by key players, and availability of technologically advanced healthcare infrastructure have resulted in North America’s more significant revenue share in the market. Asia-Pacific is expected to have substantial growth in this market. The Chinese DNA sequencing market is expected to grow at a CAGR of 19% from 2017 to 2022.

 

DNA Sequencing Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

Market size value in 2021

USD 10.5 billion

Revenue forecast in 2030

USD 44 billion

Growth rate

CAGR of 17.12%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By product, By technology, By workflow, by application, By end-use and By region.

By Product

Consumables, Instruments, Services

By Technology

Sanger Sequencing, Next-Generation Sequencing (NGS), Third Generation DNA Sequencing

By Workflow

Pre-sequencing, Sequencing, Data Analysis

By Application

Oncology, Reproductive health, Clinical Investigation, Agri genomics and Forensics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology and Drug Development, Consumer Genomics, Others

By End-Use

Academic Research, Clinical Research, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other Users

By Region

Asia Pacific, North America, Europe, and LAMEA

Country Scope

US, Mexico, Canada, Germany, UK, France, China, Japan, India etc.

Company Usability Profiles

Merck KGaA, Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., F. Hoffman-La Roche Ltd., Siemens Healthineers AG, Pacific Biosciences, Eppendorf, OpenTrons, Gilson, Neotec, TTP Labtech Ltd., Beckman Coulter, Element Biosciences, Inc.

Pricing and purchase options

Customized buying options are available to meet your exact research needs.

 

Global DNA Sequencing Market Competitive Landscape Analysis

The market is very competitive and has a few significant players. These companies make substantial efforts to address consumer demand. They make substantial investments in production, distribution, and total quality management for their portfolio expansion. The key players in this market are:

  • Merck KGaA

  • Thermo Fischer Scientific, Inc.

  • Agilent Technologies, Inc.

  • Illumina, Inc.

  • F. Hoffman-La Roche Ltd.

  • Siemens Healthineers AG

  • Pacific Biosciences

  • Eppendorf

  • OpenTrons

  • Gilson

  • Neotec

  • TTP Labtech Ltd.

  • Beckman Coulter

  • Element Biosciences, Inc.

DNA sequencing Market Based on Region

Recent Developments

  • In March 2022, Element Biosciences, Inc. announced the commercial launch of its Element AVIT system. Element believes that through this product launch, the company is delivering on its vision to expand access to high-quality, low-cost, and easy to use genomics tools.

 

  • In March 2022, Illumina announced its partnership with Trivitron to develop next-generation sequencing (NGS) based in-vitro diagnostic (IVD) tests In India. Illumina believes that the company can make genomic technology and precision medicine available for all through this partnership.

 

  • In January 2021, SPT Labtech announced its collaboration with Thermo Fisher Scientific to jointly market solutions that could enable variant detection at a fraction of the cost. SPT Labtech and Thermo Fisher believe that by automating and miniaturising NGS processes, scientists can expand their research’s scope and ultimately generate insights into human health.

 

  • In May 2020, F. Hoffman-La Roche Ltd. announced the acquisition of Stratos Genomics to advance the development of Roche’s nanopore sequencer. Roche believes that the acquisition can help address clinical research demands, which could help resolve patient needs.

 

  • In January 2020, Agilent Technologies, Inc. announced the launch of its Agilent SureSelect XT HS2 DNA kit to address key challenges laboratories might encounter while preparing DNA sequencing libraries. Agilent Technologies believes that the kit will help laboratory scientists accelerate their capture-based enrichment library preparation without sacrificing quality.

 

Various Leading DNA Sequencing Devices that Key Market Leaders Develop

Name of the Product

Function

Company

OpenTrons OT-2

Pipetting for genomics, proteomics, cell-based assays and drug discovery

OpenTrons

Gilson Pipetmax

Pipetting for biological assays

Gilson

Neotec EzMate

Pipetting for PCR/ qPCR sample preparation

Neotec

TTP Labtech Mosquito HV Genomics

Pipetting for miniaturised molecular biology

TTP Labtech Ltd.

Beckman Coulter Labcyte Echo 525

Biochemical and Genomics Reagent Transfer

Beckman Coulter

 

Frequently Asked Question About This Report

The major factors that contribute to the growth of the market are technological advancements in DNA sequencing and increasing applications in clinical diagnosis and drug discovery.

The Next-Generation Sequencing segment held the highest share in the market based on technology, with a revenue share of 58.6% in 2019.

The oncology segment held the maximum revenue share in the market, with a share of 24.4% in 2019.

The North American region held the most significant revenue share in the market, with a revenue contribution of 44.3% in 2019.

The global DNA sequencing market is expected to grow at a compound annual growth rate (CAGR) of 17.12 % from 2021 to 2030 to reach USD 44 Billion by 2030.

The global DNA sequencing market size was $ 10.5 Bn in 2021 and is predicted to reach $ 44 Bn by 2030, with a CAGR of 17.12 %.


Sources

https://www.genome.gov/17516714/2006-release-about-whole-genome-association-studies

https://rarediseases.org/wp-content/uploads/2019/01/RDD-FAQ-2019.pdf

https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost

https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12980

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161442/

https://sapac.illumina.com/science/technology/next-generation-sequencing/beginners/ngs-cost.html

 

c1.   Introduction

       1.1. Study Objective

       1.2. market Definition        

       1.3. Study Scope

              1.3.1. markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

      2.4.1.             Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing market Size by Top-Down Analysis

       2.5. market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1  DNA Sequencing market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      market Summary

4. Industry Outlook

       4.1  market Snapshot

       4.2  Global DNA Sequencing market

              4.2.1      Global DNA Sequencing market, 2021 – 2028 (USD Million)

       4.3  Regional Business Analysis

              4.3.1      Global DNA Sequencing market, by Region, 2021 - 2030 (USD Million)

       4.4  By Product Business Analysis

              4.4.1      Global DNA Sequencing market,  By Product, 2021 - 2030 (USD Million)

       4.5  By Technology Business Analysis

              4.5.1      Global DNA Sequencing market,  By Technology, 2021 - 2030 (USD Million)

       4.6  By Workflow Business Analysis

              4.6.1      Global DNA Sequencing market,  By Workflow, 2021 - 2030 (USD Million)

       4.7  By End-User Business Analysis

              4.7.1      Global DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

       4.8  ApplicationBusiness Analysis

              4.8.1      Global DNA Sequencing market, By Application, 2021 - 2030 (USD Million)

       4.9  Value Chain Analysis

       4.10               market Variable Analysis

              4.10.1    market Drivers Analysis

      4.10.2            market Restraints Analysis

4.11       Business Environment Analysis Tool

              4.11.1    DNA Sequencing market PEST analysis

              4.11.2    DNA Sequencing market Porter’s analysis

       4.12               Penetration & Growth Prospect Mapping

5. market Dynamics

       5.1. Introduction

       5.2. market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On DNA Sequencing market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              Technology Analysis

              5.11.1.   Trends in Technology (2014-2021)

              5.11.2.   Trends in Technology (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

       6.1. Company market Share Analysis

       6.2. Manufacturers DNA Sequencing Manufacturing Sites, Area Served, Product Type

       6.3. DNA Sequencing market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global DNA Sequencing market: By Product Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Consumables

              7.3.1. Consumables market, 2021 - 2030 (USD Million)

       7.4. Instruments

              7.4.1. Instruments market, 2021 - 2030 (USD Million)

       7.5.  Services

             7.5.1 Services market, 2021 - 2030 (USD Million)

8. Global DNA Sequencing market: By Technology Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Sanger Sequencing

              8.3.1. Sanger Sequencing market, 2021 - 2030 (USD Million)

       8.4. Next-Generation Sequencing (NGS)

              8.4.1. Next-Generation Sequencing (NGS) market, 2021 - 2030 (USD Million)

                       8.4.1.1 Whole Genome Sequencing (WGS) market, 2021 - 2030 (USD Million)

                       8.4.1.2 Whole Exome Sequencing (WES) market, 2021 - 2030 (USD Million)

                       8.4.1.3 Targeted Sequencing and Resequencing

       8.5 Third Generation DNA Sequencing

              8.5.1 Third Generation DNA Sequencing market, 2021 - 2030 (USD Million)

                     8.5.1 Single-Molecule Real-Time Sequencing (SMRT) market, 2021 - 2030 (USD Million)

                     8.5.1 Nanopore Sequencing market, 2021 - 2030 (USD Million)

 

9. Global DNA Sequencing market: By Workflow Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Pre-sequencing

              9.3.1. Pre-sequencing market, 2021 - 2030 (USD Million)

       9.4. Sequencing

              9.4.1. Sequencing market, 2021 - 2030 (USD Million)

       9.5 Data Analysis

              9.5.1 Data Analysis market, 2021 - 2030 (USD Million)

10. Global DNA Sequencing market: By End-User Segment Analysis

10.1. Introduction

10.2. Sales Volume & Revenue Analysis (2021-2030)

10.3. Academic Research

10.3.1. Academic Research market, 2021 - 2030 (USD Million)

10.4. Clinical Research

10.4.1. Clinical Research market, 2021 - 2030 (USD Million)

10.5 Hospitals and Clinics

10.5.1 Hospitals and Clinics market, 2021 - 2030 (USD Million)

10.6 Pharmaceutical and Biotechnology Companies

10.6.1 Pharmaceutical and Biotechnology Companies market, 2021 - 2030 (USD Million)

10.7 Others Users

10.7.1 Others Users market, 2021 - 2030 (USD Million)

 

11. Global DNA Sequencing market: By Application Segment Analysis

11.1. Introduction

11.2. Sales Volume & Revenue Analysis (2021-2030)

11.3. Oncology

11.3.1. Oncology market, 2021 - 2030 (USD Million)

11.4.Reproductive health

11.4.1. Reproductive health market, 2021 - 2030 (USD Million)

11.5 Clinical Investigation

              11.5.1 Clinical Investigation market, 2021 - 2030 (USD Million)

11.6 Agri genomics and Forensics

              11.6.1 Agri genomics and Forensics market, 2021 - 2030 (USD Million)

11.7 HLA Typing/Immune System Monitoring

              11.7.1 HLA Typing/Immune System Monitoring market, 2021 - 2030 (USD Million)

11.8 Metagenomics, Epidemiology and Drug Development

              11.8.1 Metagenomics, Epidemiology and Drug Development market, 2021 - 2030 (USD Million)

11.9 Consumer Genomics

              11.9.1 Consumer Genomics market, 2021 - 2030 (USD Million)

 

12. Global DNA Sequencing market: Region

12.1       North America

              12.1.1.   North America DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

 12.1.4. North America DNA Sequencing market, By Application, 2021 - 2030 (USD Million)

 

12.1.5.  North America DNA Sequencing market, by Country, 2021 - 2030 (USD Million)

12.1.4.1.              U.S.

                     12.1.4.1.1.   U.S. DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.1.4.2.      Canada

12.1.4.2.1.          Canada DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

                     12.1.4.2.2.   Canada DNA Sequencing market, By Region, 2021 - 2030 (USD Million)

                     12.1.4.2.3.   Canada DNA Sequencing market, by Applications, 2021 - 2030 (USD Million)

12.2.      Europe

              12.2.1.   Europe DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

              12.2.2.   Europe DNA Sequencing market, by  By Application, 2021 - 2030 (USD Million)

12.2.5.  Europe DNA Sequencing market, by country, 2021 - 2030 (USD Million)

12.2.4.1    U.K.

12.2.4.1.1.          U.K. DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.2.4.1.2.          U.K. DNA Sequencing market, By Applications, 2021 - 2030 (USD Million)

12.2.4.1.3.          U.K. DNA Sequencing market, by Region, 2021 - 2030 (USD Million)

12.2.4.2.              Germany

12.2.4.2.1.          Germany DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.2.4.2.2.          Germany DNA Sequencing market, By Application, 2021 - 2030 (USD Million)

12.2.4.2.3.          Germany DNA Sequencing market, by Region, 2021 - 2030 (USD Million)

12.2.4.3.              France

12.2.4.3.1.          France DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.2.4.3.2.          France DNA Sequencing market, By Region, 2021 - 2030 (USD Million)

12.2.4.3.3.          France DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.2.4.4.              Rest of Europe

12.2.4.4.1.          Rest of Europe DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.2.4.4.2.          Rest of Europe DNA Sequencing market, By Region, 2021 - 2030 (USD Million)

12.2.4.4.3.          Rest of Europe DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.3.      Asia Pacific

12.3.1.  Asia Pacific DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.3.2.  Asia Pacific DNA Sequencing market, By Application, 2021 - 2030 (USD Million)

12.3.5.  Asia Pacific DNA Sequencing market, by country, 2021 - 2030 (USD Million)

12.3.4.1.              China

12.3.4.1.1.          China DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.3.4.1.2.          China DNA Sequencing market, By Region, 2021 - 2030 (USD Million)

12.3.4.1.3.          China DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.3.4.2.              India

12.3.4.2.1.          India DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.3.4.2.2.          India DNA Sequencing market, By Region, 2021 - 2030 (USD Million)

12.3.4.2.3.          India DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.3.4.3.              Japan

12.3.4.3.1.          JapanDNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.3.4.3.3.          Japan DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.3.4.4.              South Korea

12.3.4.4.1.          South Korea DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.3.4.4.3.          South Korea DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.3.4.5.             Rest of ASIA PACIFIC

12.3.4.5.1.          Rest of ASIA PACIFICDNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.3.4.5.3.          Rest of ASIA PACIFICDNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.4.      Latin America

12.4.1.  Latin America DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.4.3.  Latin America DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.4.4.  Latin America DNA Sequencing market, by country, 2021 - 2030 (USD Million)

12.4.4.1.              Brazil

12.4.4.1.1.          Brazil DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.4.4.1.3.          Brazil DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.4.4.2.              Mexico

12.4.4.2.1.          Mexico DNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.4.4.2.3.          Mexico DNA Sequencing market, by Application, 2021 - 2030 (USD Million)

12.4.4.3.              Rest of the Latin America

12.4.4.3.1.          Rest of the Latin AmericaDNA Sequencing market, By End-User, 2021 - 2030 (USD Million)

12.4.4.3.3.          Rest of the Latin AmericaDNA Sequencing market, by Application, 2021 - 2030 (USD Million)

13. Competitive Landscape

13.1 Merck KGaA

13.1.1.  Company overview

13.1.2.  Financial performance

13.1.3.  Product Portfolio Analysis

13.1.4.  Business Strategy & Recent Development

13.2. Thermo Fischer Scientific, Inc.

13.2.1.  Company overview

13.2.2.  Financial performance

13.2.3.  Product Portfolio Analysis

13.2.4.  Business Strategy & Recent Development

13.3. Agilent Technologies, Inc. 

13.3.1.  Company overview

13.3.2.  Financial performance

13.3.3.  Product Portfolio Analysis

13.3.4.  Business Strategy & Recent Development

13.4. Illumina, Inc.

13.4.1.  Company overview

13.4.2.  Financial performance

13.4.3.  Product Portfolio Analysis

13.4.4.  Business Strategy & Recent Development

13.5. F. Hoffman-La Roche Ltd.

13.5.1.  Company overview

13.5.2.  Financial performance

13.5.3.  Product Portfolio Analysis

13.5.4.  Business Strategy & Recent Development

13.6. Siemens AG.

13.6.1.  Company overview

13.6.2.  Financial performance

13.6.3.  Product Portfolio Analysis

13.6.4.  Business Strategy & Recent Development

13.7. Pacific Biosciences.

13.7.1.  Company overview

13.7.2.  Financial performance

13.7.3.  Product Portfolio Analysis

13.7.4.  Business Strategy & Recent Development

13.8. Eppendorf.

13.8.1.  Company overview

13.8.2.  Financial performance

13.8.3.  Product Portfolio Analysis

13.8.4.  Business Strategy & Recent Development

 

List of Tables (52 Tables)

TABLE 1.  DNA Sequencing market, By Product, 2021-2030 (USD Million)

TABLE 2.  DNA Sequencing market FOR Consumables, BY REGION, 2021-2030 (USD Million)

TABLE 3.  DNA Sequencing market FOR Instruments, BY REGION, 2021-2030 (USD Million)

TABLE 4.  DNA Sequencing market FOR Services, BY REGION, 2021-2030 (USD Million)

TABLE 5.  DNA Sequencing market FOR Software, BY REGION, 2021-2030 (USD Million)

TABLE 6.  DNA Sequencing market, By Technology, 2021-2030 (USD Million)

TABLE 7.  DNA Sequencing market FOR Sanger Sequencing, BY REGION, 2021-2030 (USD Million)

TABLE 8.  DNA Sequencing market FOR Next-Generation Sequencing (NGS), BY REGION, 2021-2030 (USD Million)

TABLE 9.  DNA Sequencing market FOR Third Generation DNA Sequencing, BY REGION, 2021-2030 (USD Million)

TABLE 10.  DNA Sequencing market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million)

TABLE 11.  DNA Sequencing market, By Workflow, 2021-2030 (USD Million)

TABLE 12.  DNA Sequencing market FOR Pre-sequencing, BY REGION, 2021-2030 (USD Million)

TABLE 13.  DNA Sequencing market FOR Sequencing, BY REGION, 2021-2030 (USD Million)

TABLE 14.  DNA Sequencing market FOR Data Analysis, BY REGION, 2021-2030 (USD Million)

TABLE 15.  DNA Sequencing market, By End-User, 2021-2030 (USD Million)

TABLE 16.  DNA Sequencing market FOR Academic Research, BY REGION, 2021-2030 (USD Million)

TABLE 17.  DNA Sequencing market FOR Clinical Research, BY REGION, 2021-2030 (USD Million)

TABLE 18.  DNA Sequencing market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million)

TABLE 19. DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 20. DNA Sequencing market FOR Oncology, BY REGION, 2021-2030 (USD Million)

TABLE 21. DNA Sequencing market FOR Reproductive health, BY REGION, 2021-2030 (USD Million)

TABLE 22. DNA Sequencing market FOR Clinical Investigation, BY REGION, 2021-2030 (USD Million)

TABLE 23. DNA Sequencing market, BY REGION, 2021-2030 (USD Million)

TABLE 24. NORTH AMERICA DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 25. NORTH AMERICA DNA Sequencing market, BY Applications, 2021-2030 (USD Million)

TABLE 26. NORTH AMERICA DNA Sequencing market, By End-User, 2021-2030 (USD Million)

TABLE 27. NORTH AMERICA DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 28. EUROPE DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 29. EUROPE DNA Sequencing market, By End-User, 2021-2030 (USD Million)

TABLE 30. EUROPE DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 31. ASIA-PACIFIC DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 32. ASIA-PACIFIC DNA Sequencing market, By End-User, 2021-2030 (USD Million)

TABLE 33. ASIA-PACIFIC DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 34. LAMEA DNA Sequencing market, BY COUNTRY, 2021-2030 (USD Million)

TABLE 35. LAMEA DNA Sequencing market, By End-User, 2021-2030 (USD Million)

TABLE 36. LAMEA DNA Sequencing market, BY APPLICATION, 2021-2030 (USD Million)

TABLE 37. Merck KGaA: COMPANY SNAPSHOT

TABLE 38. Merck KGaA: OPERATING SEGMENTS

TABLE 39. Thermo Fischer Scientific, Inc: COMPANY SNAPSHOT

TABLE 40. Thermo Fischer Scientific, Inc: OPERATING SEGMENTS

TABLE 41. Agilent Technologies, Inc: COMPANY SNAPSHOT

TABLE 42. Agilent Technologies, Inc: OPERATING SEGMENTS

TABLE 43. Illumina, Inc: COMPANY SNAPSHOT

TABLE 44. Illumina, Inc: OPERATING SEGMENTS

TABLE 45. F. Hoffman-La Roche Ltd: COMPANY SNAPSHOT

TABLE 46. F. Hoffman-La Roche Ltd: OPERATING SEGMENTS

TABLE 47. Siemens AG: COMPANY SNAPSHOT

TABLE 48. Siemens AG: OPERATING SEGMENTS

TABLE 49. Pacific Biosciences: COMPANY SNAPSHOT

TABLE 50. Pacific Biosciences: OPERATING SEGMENTS

TABLE 51. Eppendorf: COMPANY SNAPSHOT

TABLE 52. Eppendorf: OPERATING SEGMENTS

 

List of Figures (26 Figures)

Figure 1 DNA Sequencing market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries: DNA Sequencing market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 DNA Sequencing market: Application-Based Estimation

Figure 6 Top 8 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2021

Figure 8 Import Data for DNA Sequencing, By Country, 2016–2021 (USD Thousand)

Figure 9 Export Data for DNA Sequencing, By Country, 2016–2021 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 DNA Sequencing market, By Product, 2019 vs. 2025 (USD Million)

Figure 12 DNA Sequencing market, By Technology, 2019 vs. 2025 (USD Million)

Figure 13 DNA Sequencing market, By Workflow, 2019 vs. 2025 (USD Million)

Figure 14 DNA Sequencing market, By End-User, 2019 vs. 2025 (USD Million)

Figure 15 DNA Sequencing market Share, By Application Type, 2019 vs. 2025

Figure 16 Geographical Snapshot of the DNA Sequencing market

Figure 17 Consumables to Witness Higher CAGR in DNA Sequencing market for Product Segment during Forecast Period.

Figure 18 Next-Generation DNA Sequencing to Witness Higher CAGR in DNA Sequencing market for Technology Segment during Forecast Period.

Figure 19 Sequencing segment to Witness Higher CAGR in DNA Sequencing market for Workflow Segment during Forecast Period.

Figure 20 Academic research to Witness Higher CAGR in DNA Sequencing market for End-User Segment during Forecast Period.

Figure 21 Oncology segment to Witness Higher CAGR in DNA Sequencing market for Application Segment during Forecast Period.

Figure 22 North America Accounted for the Largest Share of the DNA Sequencing market, By Regional Basis, in 2019

Figure 23 DNA Sequencing market: Drivers, Restraints, Opportunities, and Challenges

Figure 24 North America: DNA Sequencing market Snapshot

Figure 25 Asia Pacific: DNA Sequencing market Snapshot

Figure 26 Vendor Dive: Evaluation Overview

Choose License Type


$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization
Related Reports
Buy Now
Request Sample

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: +1-315-636-4233
  • UK: +44-162-237-0614
  • IN: +91-826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.